Table 2.
Patient characteristics
| Number of patients (n = 37) (%) | |
|---|---|
| Median age (range) |
50 (23–70) |
| Gender | |
| Male |
23 (62.2) |
| Female |
14 (37.8) |
| Diagnosis | |
| Acute myeloid leukemia |
9 (24.3) |
| Acute lymphocytic leukemia |
3 (8.1) |
| Acute biphenotypic leukemia |
1 (2.7) |
| Malignant lymphoma |
20 (54.1) |
| ATLL |
3 (8.1) |
| Myelodysplastic syndrome |
1 (2.7) |
| Medical treatment | |
| Allogeneic BMT |
7 (18.9) |
| Autologous PBSCT |
4 (10.8) |
| Allogeneic PBSCT |
1 (2.7) |
| CBT |
2 (5.4) |
| Chemotherapy alone |
23 (62.2) |
| Myelosuppression grading [courses]* | |
| Grade B |
34 (91.9) [64] |
| Grade C |
18 (48.6) [22] |
| Grade D | 15 (40.5) [15] |
ATLL Adult T-cell leukemia/lymphoma, BMT Bone marrow transplantation, PBSCT Peripheral blood stem cell transplantation.
CBT Cord blood transplantation.
*Course of treatment was counted. Some patients were graded several times.